{"entity":{"type":"insider","cik":"0001350693","url":"/insider/0001350693","json_url":"/insider/0001350693.json","name":"BEHL CHARAN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":13,"first":"2008-01-28","last":"2008-09-22","span_basis":"filed_date"},"name_variants":[{"name":"BEHL CHARAN","source":"filing","n_filings":13,"first_seen":"2008-01-28","last_seen":"2008-09-22"}],"transactions":[{"id":2552224,"accession":"0000930413-08-005628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-005628","line_url":"/filing/0000930413-08-005628#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":900.0,"total_display":"900.00","total_whole":"900","shares_owned_after":600000.0,"shares_owned_after_display":"600,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-19","filed_date":"2008-09-22","scope":"insider"},{"id":3339983,"accession":"0000930413-08-004395","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000930413-08-004395","line_url":"/filing/0000930413-08-004395#line-3","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":3400.0,"total_display":"3,400.00","total_whole":"3,400","shares_owned_after":580000.0,"shares_owned_after_display":"580,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-23","filed_date":"2008-07-23","scope":"insider"},{"id":2967635,"accession":"0000930413-08-004437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000930413-08-004437","line_url":"/filing/0000930413-08-004437","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.3386,"price_display":"0.34","price_state":"stated","total_value":3386.0,"total_display":"3,386.00","total_whole":"3,386","shares_owned_after":589300.0,"shares_owned_after_display":"589,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-23","filed_date":"2008-07-25","scope":"insider","n_lines":2},{"id":3339974,"accession":"0000930413-08-004395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000930413-08-004395","line_url":"/filing/0000930413-08-004395","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.377768,"price_display":"0.38","price_state":"stated","total_value":3777.68,"total_display":"3,777.68","total_whole":"3,778","shares_owned_after":570000.0,"shares_owned_after_display":"570,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-21","filed_date":"2008-07-23","scope":"insider","n_lines":2},{"id":3957147,"accession":"0000930413-08-004337","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000930413-08-004337","line_url":"/filing/0000930413-08-004337#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":3700.0,"total_display":"3,700.00","total_whole":"3,700","shares_owned_after":560000.0,"shares_owned_after_display":"560,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-18","filed_date":"2008-07-18","scope":"insider"},{"id":3957146,"accession":"0000930413-08-004337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-004337","line_url":"/filing/0000930413-08-004337#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":5250.0,"total_display":"5,250.00","total_whole":"5,250","shares_owned_after":550000.0,"shares_owned_after_display":"550,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-17","filed_date":"2008-07-18","scope":"insider"},{"id":2436338,"accession":"0000930413-08-004299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-004299","line_url":"/filing/0000930413-08-004299#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":1700.0,"total_display":"1,700.00","total_whole":"1,700","shares_owned_after":535000.0,"shares_owned_after_display":"535,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-15","filed_date":"2008-07-15","scope":"insider"},{"id":3672200,"accession":"0000930413-08-004226","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000930413-08-004226","line_url":"/filing/0000930413-08-004226","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.39346133333333333,"price_display":"0.39","price_state":"stated","total_value":5901.92,"total_display":"5,901.92","total_whole":"5,902","shares_owned_after":527404.0,"shares_owned_after_display":"527,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-09","filed_date":"2008-07-09","scope":"insider","n_lines":3},{"id":3236381,"accession":"0000930413-08-002189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-002189","line_url":"/filing/0000930413-08-002189#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":515000.0,"shares_owned_after_display":"515,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-02","filed_date":"2008-04-02","scope":"insider"},{"id":3236374,"accession":"0000930413-08-002076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-002076","line_url":"/filing/0000930413-08-002076#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":500000.0,"shares_owned_after_display":"500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-28","filed_date":"2008-03-28","scope":"insider"},{"id":3732856,"accession":"0000930413-08-002027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-002027","line_url":"/filing/0000930413-08-002027#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.959,"price_display":"0.96","price_state":"stated","total_value":4795.0,"total_display":"4,795.00","total_whole":"4,795","shares_owned_after":495000.0,"shares_owned_after_display":"495,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-03-26","filed_date":"2008-03-27","scope":"insider"},{"id":3922087,"accession":"0000930413-08-000822","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000930413-08-000822","line_url":"/filing/0000930413-08-000822","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.016902,"price_display":"1.02","price_state":"stated","total_value":5084.51,"total_display":"5,084.51","total_whole":"5,085","shares_owned_after":489061.0,"shares_owned_after_display":"489,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-08","filed_date":"2008-02-08","scope":"insider","n_lines":2},{"id":3922083,"accession":"0000930413-08-000822","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-000822","line_url":"/filing/0000930413-08-000822#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":485000.0,"shares_owned_after_display":"485,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-07","filed_date":"2008-02-08","scope":"insider"},{"id":3978106,"accession":"0000930413-08-000780","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000930413-08-000780","line_url":"/filing/0000930413-08-000780","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.75692,"price_display":"0.76","price_state":"stated","total_value":18923.0,"total_display":"18,923.00","total_whole":"18,923","shares_owned_after":475000.0,"shares_owned_after_display":"475,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-05","filed_date":"2008-02-06","scope":"insider","n_lines":4},{"id":3732854,"accession":"0000930413-08-000693","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000930413-08-000693","line_url":"/filing/0000930413-08-000693","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.9366666666666666,"price_display":"0.94","price_state":"stated","total_value":14050.0,"total_display":"14,050.00","total_whole":"14,050","shares_owned_after":445000.0,"shares_owned_after_display":"445,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-30","filed_date":"2008-01-30","scope":"insider","n_lines":2},{"id":3732850,"accession":"0000930413-08-000693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-000693","line_url":"/filing/0000930413-08-000693#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":435000.0,"shares_owned_after_display":"435,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-29","filed_date":"2008-01-30","scope":"insider"},{"id":3843723,"accession":"0000930413-08-000589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000930413-08-000589","line_url":"/filing/0000930413-08-000589#line-2","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":4600.0,"total_display":"4,600.00","total_whole":"4,600","shares_owned_after":425000.0,"shares_owned_after_display":"425,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-28","filed_date":"2008-01-28","scope":"insider"},{"id":3843721,"accession":"0000930413-08-000589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-08-000589","line_url":"/filing/0000930413-08-000589#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001350693","owner_name":"BEHL CHARAN","owner_display_name":"BEHL CHARAN","owner_url":"/insider/0001350693","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":5800.0,"total_display":"5,800.00","total_whole":"5,800","shares_owned_after":421000.0,"shares_owned_after_display":"421,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-25","filed_date":"2008-01-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":27,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001053369","name":"ELITE PHARMACEUTICALS INC /DE/","url":"/issuer/0001053369","role":"Other","n_filings":13,"first_seen":"2008-01-28","last_seen":"2008-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001350693","retrieved_at":"2026-08-23T03:26:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}